The only good thing about the e-prescribing (all Rxx in the State are now done electronically, you don't even get paper rx when you leave the doctor's office you just tell them your pharmacy) is that I can call him up and get things changed or ordered without needing an office visit, which was the case for first C-II and then all controlled substances. But now all he needs to do is enter it into the computer. He can also see everything else that I'm getting, so doctor shopping is dead. Also pharmacies used to never really check ID even for serious CDS, even multiple ones, even at corporate chains, now they do and actually keep copies on file, so the days of collecting prescriptions under different names are dead, too. But we're getting off topic ...
Opiates in particular there seems to be a lot of variation place to place, largely I think due to worries about abuse. Ketobemidone I've only heard about on Bluelight, it's Schedule I in the U.S. as are many opioids which are not used in clinical practice here, but may be elsewhere. Judging from what I've read it does have quite high abuse potential, but putting it in a category above oxymorphone and oxycodone seems a bit much, although basically all the opioids not used clinically are Schedule I here, and ketobemidone might have some clinical applications for which it would be particularly well-suited due to it's unique properties.
There's a similar situation going on with benzos, although their not being C-I/II makes some analogs (like etizolam although not technically a benzodiazepine) "not illegal" (not-not-legal, but importation being a gray are and sale being a no-no) and not subject to the analog act; bromazepam, one of my favorites, however, is scheduled, but is not used in clinical practice, which I find unfortunate, it's very Valium-like in it's nice balance of anxiolytic, hypnotic, and muscle-relaxant qualities but with a more manageable T½, it is a favorite of mine but at best a rare treat now (I once got a large batch from overseas and used it extensively at therapeutic doses, haven't had any in years), it is however used with some frequency in Europe and elsewhere.